Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis-Reference-Cited by-同舟云学术

Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis

Published:2020-06-29 Issue:15 Volume:26 Page:3928-3935
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Fader Amanda N.,Roque Dana M.^ORCID,Siegel Eric^ORCID,Buza Natalia,Hui Pei,Abdelghany Osama,Chambers Setsuko,Secord Angeles Alvarez,Havrilesky Laura,O'Malley David M.,Backes Floor J.^ORCID,Nevadunsky Nicole^ORCID,Edraki Babak,Pikaart Dirk,Lowery William,ElSahwi Karim,Celano Paul^ORCID,Bellone Stefania,Azodi Masoud,Litkouhi Babak,Ratner Elena,Silasi Dan-Arin,Schwartz Peter E.,Santin Alessandro D.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Targeting of the Human Epidermal Growth Factor Receptor-2 (HER2) Genes across Various Cancers;International Journal of Molecular Sciences;2024-01-15

2. Knowledge mapping of immunotherapy in cervical carcinoma: a bibliometric analysis (2000-2023);Frontiers in Immunology;2024-01-09

3. Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions;Gynecologic Oncology;2024-01

4. Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement;Journal of Gynecologic Oncology;2024

5. Moving into the modern era of molecular classification for endometrial cancer;Journal of Surgical Oncology;2023-12-15